Buscar
Mostrando ítems 1-10 de 30
The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future
Coronavirus disease 2019 (COVID
-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS
-CoV-2), is currently defined as the worst pandemic disease.
SARS
-CoV-2 infects human cells via the binding of its ...
Modulation of the renin-angiotensin-aldosterone system in sepsis: a new therapeutic approach?
(Informa Healthcare, 2010-01-01)
Importance of the field: Severe sepsis is characterized by relative hypotension associated with a high cardiac output, peripheral vasodilation, and organ dysfunction. the renin-angiotensin-aldosterone system (RAAS) is ...
Fallacies in medical practice: renin-angiotensin-aldosterone system inhibition and COVID-19 as a paradigm
In emergency situations, like during the coronavirus disease 2019 (COVID-19)
pandemic, medical community looks for quick answers and guidance. Under these
circumstances, experts instead of admitting ignorance, feel obliged ...
Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis
(Elsevier, 2020-05-28)
Background and rationale: Some studies of hospitalized patients suggested that the risk of death and/or severe illness due to COVID-19 is not associated with the use of angiotensin-converting enzyme inhibitors (ACEIs) ...
Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
Background Concerns have been raised about the possibility that inhibitors of the renin–angiotensin–aldosterone
system (RAAS) could predispose individuals to severe COVID-19; however, epidemiological evidence is lacking. ...
Bloqueo del eje renina angiontensina aldosterona (RAAS) en la enfermedad renal diabética. Más allá del control de la hipertensión arterial
(EFACIM. Editorial de la Facultad de Ciencias Médicas - Universidad Nacional de Asunción, 2023)
La enfermedad renal diabética (ERD) es una comorbilidad con alta prevalencia a nivel mundial,
siendo una de las complicaciones más frecuentes de la diabetes mellitus (DM). La ERD se
relaciona con complicaciones ...
COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?
The coronavirus disease (COVID-19) has spread all around the world in a very short period of time. Recent data
are showing significant prevalence of arterial hypertension and cardiovascular diseases (CVD) among patients
with ...
Sodium‑glucose cotransporter 2 inhibitors (SGLT2i): renal implications
(Springer, 2020)
Type 2 diabetes mellitus (DM2) is a chronic condition that affects more than 400 million individuals worldwide. In DM2 patients, an appropriate glycemic control slows the onset and delays the progression of all its micro ...